uk en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LA LAW FIRM (Legal Alliance) founded in 1995, is today one of the leading Ukrainian law firms that provides comprehensive corporate counselling and practical support to national and global companies in Ukraine, СEE & Central Asia.

OUR CLIENTS represent life sciences industries including healthcare and pharmaceuticals, medical devices, cosmetics, biotechnology as well as healthcare institutions.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen LA Law Firm as their legal advisor.

1836
On September 18, 2025, at a meeting of the constituent assembly, a decision was adopted to establish the National Medicines Verification Organisation in Ukraine.
2002
Almost UAH 5 billion. This is the total amount of the fine imposed by the Antimonopoly Committee of Ukraine (AMCU) in its decision No. 370-r dated 31.07.2025 on
2679
Key changes: The government has clarified the 20% sales quota for medicinal products and tightened requirements for pharmacy chains.
1245
​The Legal Practice publishing house has announced the release of the twenty-second issue of Ukrainian Law Firms. A Handbook for Foreign Clients.
1628
Last week, on July 10, 2025, LA Law Firm and UkrComExpo co-hosted PHARMA CONSYLIUM "Promotion of medicines. Restrictions and control. New conditions for working with HCPs".
1601
LA advised an international pharmaceutical company Roche on investments in Ukraine's pharmaceutical sector by establishing local medicine production facilities and participating in a PPP.
2146
LA Law Firm has improved its standing in the "Market Leaders. Ranking of Law Firms — 2025" an annual assessment by the editorial board of Yuridychna Gazeta.
1715
Medical Procurement of Ukraine and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
826
On July 3, 2025, Law of Ukraine No. 4472-IX came into force, expanding patient access to medicinal products. The law introduces new opportunities for the procurement of medicinal products under managed entry agreements.
888
Lidiia Sanzharovska and Viktoriya Hanzhelo participated in the pharmaceutical forum "Pharmexpert 2025. eCTD and Pricing in Ukraine – a Strategic Path to Integration into the International Regulatory Space".
If you find out a mistake, please, mark it and select Ctrl+Enter to inform us